INCYTE CORPORATION Defined Benefit Plan, Amortization of Gain (Loss)
INCYTE CORPORATION (INCY) reported Defined Benefit Plan, Amortization of Gain (Loss) of -$127.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses · last filed 2026-04-28
- INCYTE CORPORATION defined benefit plan, amortization of gain (loss) for the quarter ending 2026-03-31 was -$127.00K.
- INCYTE CORPORATION defined benefit plan, amortization of gain (loss) for the quarter ending 2025-03-31 was -$318.00K.
- INCYTE CORPORATION defined benefit plan, amortization of gain (loss) for fiscal 2025 was -$1.39M.
- INCYTE CORPORATION defined benefit plan, amortization of gain (loss) for fiscal 2024 was -$673.00K.
- INCYTE CORPORATION defined benefit plan, amortization of gain (loss) for fiscal 2023 was $0.00.
- INCYTE CORPORATION defined benefit plan, amortization of gain (loss) for fiscal 2022 was -$356.00K.
| Period end | Defined Benefit Plan, Amortization of Gain (Loss) 3 month | Defined Benefit Plan, Amortization of Gain (Loss) 12 month |
|---|---|---|
| 2026-03-31 | -$127.00K 10-Q · filed 2026-04-28 | |
| 2025-12-31 | -$1.39M 10-K · filed 2026-02-10 | |
| 2025-03-31 | -$318.00K 10-Q · filed 2026-04-28 | |
| 2024-12-31 | -$673.00K 10-K · filed 2026-02-10 | |
| 2023-12-31 | $0.00 10-K · filed 2026-02-10 | |
| 2022-12-31 | -$356.00K 10-K · filed 2025-02-10 | |
| 2021-12-31 | -$1.15M 10-K · filed 2024-02-13 | |
| 2020-12-31 | -$667.00K 10-K · filed 2023-02-07 | |
| 2019-12-31 | -$247.00K 10-K · filed 2022-02-08 | |
| 2018-12-31 | -$265.00K 10-K · filed 2021-02-09 | |
| 2017-12-31 | -$141.00K 10-K · filed 2020-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |